Corinne M. Hohl

Corinne M. Hohl

Auto-generated profile, based on publicly available information

Corinne M. Hohl

Department of Emergency Medicine, University of British Columbia, Vancouver, Canada

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
LCLindsay Cohen
Lindsay Cohen
VAValerie Athaide
Valerie Athaide
MWMaeve E. Wickham
Maeve E. Wickham
MDMary M. Doyle-Waters
Mary M. Doyle-Waters
NRNicholas G.W. Rose
Nicholas G.W. Rose
CHCorinne M. Hohl
Corinne M. Hohl

1 November 2019 in Annals of Emergency Medicine
Verified
Journal Article
Open access
ACAmber Cragg
Amber Cragg
JHJeffrey P. Hau
Jeffrey P. Hau
SWStephanie A. Woo
Stephanie A. Woo
SKSophie A. Kitchen
Sophie A. Kitchen
CLChristine Liu
Christine Liu
CHCorinne M. Hohl
Corinne M. Hohl
Increasing opioid prescribing has been linked to an epidemic of opioid misuse. Our objective is to synthesize the available evidence about patient-, prescriber-, medication-, and system-level risk factors for developing misuse among patients prescribed opioids for noncancer pain. We performed a systematic search of the scientific and gray literature for studies reporting on risk factors for prescription opioid misuse. Two reviewers independently reviewed titles, abstracts, and full texts; extracted data; and assessed study quality. We excluded studies with greater than 50% cancer patients, palliative patients, and illicit opioid initiation. When possible, we synthesized the effect sizes of dichotomous risk factors and their associations with opioid misuse, using inverse-variance random-effects meta-analysis. We calculated the mean difference between opioid misusers and nonmisusers for continuous risk factors. When studies lacked homogeneity, we synthesized their results qualitatively. Of 9,629 studies, 65 met our inclusion criteria. Among patients with outpatient opioid prescriptions, the following factors were associated with the development of misuse: any current or previous substance use (odds ratio [OR] 3.55; 95% confidence interval [CI] 2.62 to 4.82), any mental health diagnosis (OR 2.45; 95% CI 1.91 to 3.15), younger age (OR 2.19; 95% CI 1.81 to 2.64), and male sex (OR 1.23; 95% CI 1.10 to 1.36). Although clinicians should endeavor to offer alternative pain management strategies to all patients, those who are younger, are male patients, and report a history of or current substance use or mental health diagnoses were associated with a greater risk of developing opioid misuse. Clinicians should consider prioritizing alternative pain management strategies for these higher-risk patients.

1 May 2014 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
CHCorinne M Hohl
Corinne M Hohl
AKAndrei Karpov
Andrei Karpov
LRLisa Reddekopp
Lisa Reddekopp
JSJürgen Stausberg
Jürgen Stausberg
Background Adverse drug events, the unintended and harmful effects of medications, are important outcome measures in health services research. Yet no

27 February 2018 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
CHCorinne M Hohl
Corinne M Hohl
SSSerena S Small
Serena S Small
DPDavid Peddie
David Peddie
KBKatherin Badke
Katherin Badke
CBChantelle Bailey
Chantelle Bailey
EBEllen Balka
Ellen Balka
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.

13 February 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHCorinne M. Hohl
Corinne M. Hohl
NPNilu Partovi
Nilu Partovi
IGIsabella Ghement
Isabella Ghement
MWMaeve E. Wickham
Maeve E. Wickham
KMKimberlyn McGrail
Kimberlyn McGrail
BSBoris Sobolev
Boris Sobolev
Adverse drug events are a leading cause of emergency department visits and unplanned admissions, and prolong hospital stays. Medication review interventions aim to identify adverse drug events and optimize medication use. Previous evaluations of in-hospital medication reviews have focused on interventions at discharge, with an unclear effect on health outcomes. We assessed the effect of early in-hospital pharmacist-led medication review on the health outcomes of high-risk patients. We used a quasi-randomized design to evaluate a quality improvement project in three hospitals in British Columbia, Canada. We incorporated a clinical decision rule into emergency department triage pathways, allowing nurses to identify patients at high-risk for adverse drug events. After randomly selecting the first eligible patient for participation, clinical pharmacists systematically allocated subsequent high-risk patients to medication review or usual care. Medication review included obtaining a best possible medication history and reviewing the patient’s medications for appropriateness and adverse drug events. The primary outcome was the number of days spent in-hospital over 30 days, and was ascertained using administrative data. We used median and inverse propensity score weighted logistic regression modeling to determine the effect of pharmacist-led medication review on downstream health services use. Of 10,807 high-risk patients, 6,416 received early pharmacist-led medication review and 4,391 usual care. Their baseline characteristics were balanced. The median number of hospital days was reduced by 0.48 days (95% confidence intervals [CI] = 0.00 to 0.96; p = 0.058) in the medication review group compared to usual care, representing an 8% reduction in the median length of stay. Among patients under 80 years of age, the median number of hospital days was reduced by 0.60 days (95% CI = 0.06 to 1.17; p = 0.03), representing 11% reduction in the median length of stay. There was no significant effect on emergency department revisits, admissions, readmissions, or mortality. We were limited by our inability to conduct a randomized controlled trial, but used quasi-random patient allocation methods and propensity score modeling to ensure balance between treatment groups, and administrative data to ensure blinded outcomes ascertainment. We were unable to account for alternate level of care days, and therefore, may have underestimated the treatment effect in frail elderly patients who are likely to remain in hospital while awaiting long-term care. Early pharmacist-led medication review was associated with reduced hospital-bed utilization compared to usual care among high-risk patients under 80 years of age, but not among those who were older. The results of our evaluation suggest that medication review by pharmacists in the emergency department may impact the length of hospital stay in select patient populations.

12 November 2013 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
CHCorinne M Hohl
Corinne M Hohl
LKLisa Kuramoto
Lisa Kuramoto
EYEugenia Yu
Eugenia Yu
BRBasia Rogula
Basia Rogula
JSJürgen Stausberg
Jürgen Stausberg
BSBoris Sobolev
Boris Sobolev
Adverse drug events are a frequent cause of emergency department presentations. Administrative data could be used to identify patients presenting with adverse drug events for post-market surveillance, and to conduct research in patient safety and in drug safety and effectiveness. However, such data sources have not been evaluated for their completeness with regard to adverse drug event reporting. Our objective was to determine the proportion of adverse drug events to outpatient medications diagnosed at the point-of-care in emergency departments that were documented in administrative data.